SANDRINE VAN EECKHOUDT MEDECINE INTERNE ET INFECTIOLOGIE
0686.851.951 · rovalta.com · 28/09/2026
ACTIVE
SANDRINE VAN EECKHOUDT MEDECINE INTERNE ET INFECTIOLOGIE
Financial year 2025 · Closed on 31/03/2025
Net result89,5 k €+6,2 %over 1 year
Gross margin151,8 k €+5,4 %over 1 year
Equity452,5 k €+24,7 %over 1 year
Overview
Identity
Source · BCE/KBOSANDRINE VAN EECKHOUDT MEDECINE INTERNE ET INFECTIOLOGIE is a Private limited company incorporated in 2017. Its registered office is in Overijse.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0686.851.951
- Incorporation
- 27/12/2017
- Legal form
- Private limited company
- Registered office
- Adriaanstraat 2
3090 Overijse · FlandreSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/03/2025
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 8 filingsTrend over 7 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 151,8 k € | +5.4% | 144 k € | -14.9% | 169,1 k € | -3.0% | 174,3 k € | +56.0% | 111,8 k € |
| EBITDA | 149 k € | +5.0% | 141,8 k € | -15.0% | 166,8 k € | -3.2% | 172,3 k € | +56.3% | 110,2 k € |
| Operating result | 131,4 k € | +6.0% | 124 k € | -12.8% | 142,2 k € | -3.8% | 147,8 k € | +128% | 64,8 k € |
| Net result | 89,5 k € | +6.2% | 84,3 k € | -12.2% | 96 k € | -3.6% | 99,6 k € | +143% | 40,9 k € |
| Balance sheet | |||||||||
| Equity | 452,5 k € | +24.7% | 362,9 k € | +30.2% | 278,6 k € | +52.5% | 182,7 k € | +120% | 83,1 k € |
| Total assets | 870,4 k € | +9.2% | 796,8 k € | +6.9% | 745,3 k € | +11.9% | 666,3 k € | +4.6% | 636,9 k € |
| Cash | 476 k € | +23.6% | 385,1 k € | +28.2% | 300,3 k € | +39.4% | 215,4 k € | +28.0% | 168,3 k € |
| Debts | 417,9 k € | -3.7% | 433,8 k € | -7.0% | 466,7 k € | -3.5% | 483,6 k € | -12.7% | 553,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 31/03/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
SANDRINE VAN EECKHOUDT | Mandate |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/04/2024 | 01/04/2023 | 01/04/2022 | 01/04/2021 | 01/04/2020 | 01/04/2019 |
| Closing of the financial year | 31/03/2025 | 31/03/2024 | 31/03/2023 | 31/03/2022 | 31/03/2021 | 31/03/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/10/2025 | 30/10/2024 | 31/10/2023 | 03/11/2022 | 23/11/2021 | 30/11/2020 |
| General meeting | 26/09/2025 | 27/09/2024 | 29/09/2023 | 30/09/2022 | 24/09/2021 | 25/09/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 8 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/03/2025 | 26/09/2025 | 30/10/2025 | French | |
| Micro model | 31/03/2024 | 27/09/2024 | 30/10/2024 | French | |
| Micro model | 31/03/2023 | 29/09/2023 | 31/10/2023 | French | |
| Micro model | 31/03/2022 | 30/09/2022 | 03/11/2022 | French | |
| Micro model | 31/03/2021 | 24/09/2021 | 23/11/2021 | French | |
| Micro model | 31/03/2020 | 25/09/2020 | 30/11/2020 | French | |
| Micro modelCorrection | 31/03/2019 | 27/09/2019 | 25/01/2020 | French | |
| Micro model | 31/03/2019 | 27/09/2019 | 30/10/2019 | French |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/03/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
SANDRINE VAN EECKHOUDT | Mandate |
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings7 filings
2017201820192020202120222023202420252026
SANDRINE VAN EECKHOUDT MEDECINE INTERNE ET INFECTIOLOGIE
Adriaanstraat 2, 3090 Overijse
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Adriaanstraat 2, 3090 OverijseCurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00554237 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| SANDRINE VAN EECKHOUDT MEDECINE INTERNE ET INFECTIOLOGIECurrent | accounts 2022 → 2025 | Accounts 2025 · 2025-00554237 |
Events
- 2025Annual accounts 202589,5 k €↑
- 2024Annual accounts 202484,3 k €↓
- 2023Annual accounts 202396 k €↓
- 2022Annual accounts 202299,6 k €↑
- 2021Annual accounts 202140,9 k €↑
- 2020Annual accounts 20209,9 k €↓
- 2019Annual accounts 201921,4 k €
- 27/12/2017IncorporationPrivate limited company